Filtered By:
Source: Heart Rhythm
Condition: Atrial Fibrillation

This page shows you your search results in order of date. This is page number 20.

Order by Relevance | Date

Total 356 results found since Jan 2013.

Patients with atrial fibrillation and CHADS-VASc score 1: “To anticoagulate or not to anticoagulate? That is the question!”
There is uncertainty regarding the optimal therapy for preventing thrombo-embolic stroke in patients with atrial fibrillation and CHA2DS2-VASc score 1; in fact, no extensive data on this topic are available and the latest guidelines provide different recommendations. In this paper we examine current results on use of various anti-thrombotic agents in those patients, including the newer oral anticoagulant agents. Several factors must be considered and weighted in this setting and may influence the choice of the anti-thrombotic approach: the expected incidence of both thrombo-embolic stroke and bleeding complications as well...
Source: Heart Rhythm - July 15, 2015 Category: Cardiology Authors: Giuseppe Patti, Ilaria Cavallari Tags: CRV Source Type: research

The metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of the metabolic syndrome. The metabolic syndrome describes an association between diabetes, hypertension, obesity, and dyslipidemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory Y.H. Lip Tags: Contemporary Review Source Type: research

The Metabolic Syndrome, Atrial Fibrillation and Stroke: Tackling An Emerging Epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of metabolic syndrome. Metabolic syndrome describes an association between diabetes, hypertension, obesity, dyslipidaemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory YH Lip Tags: CRV Source Type: research

Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
The prevalence of atrial fibrillation (AF) and AF-related stroke is set to increase dramatically in coming decades, with developing regions such as Latin America experiencing the greatest impact. These trends are primarily driven by aging populations and by the increasing prevalence of the metabolic syndrome. The metabolic syndrome describes an association between diabetes, hypertension, obesity, and dyslipidemia and an increased risk of cardiovascular disease. It is in large part the result of unbalanced diet and sedentary lifestyle.
Source: Heart Rhythm - June 30, 2015 Category: Cardiology Authors: Reza Hajhosseiny, Gareth K. Matthews, Gregory Y.H. Lip Tags: Contemporary Review Source Type: research

2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview
Left atrial appendage (LAA) occlusion devices have the potential to influence the clinical approach to stroke prevention in patients with atrial fibrillation (AF). A number of percutaneous techniques have been proposed, including intracardiac plugs and external ligation. Several devices have been adopted to various degrees in the United States and internationally. Only 1 (WATCHMAN, Boston Scientific, Marlborough, Massachusetts) has been evaluated in randomized controlled trials compared with the current standard of care.
Source: Heart Rhythm - June 29, 2015 Category: Cardiology Authors: Frederick A. Masoudi, Hugh Calkins, Clifford J. Kavinsky, Joseph P. Drozda, Phillip Gainsley, David J. Slotwiner, Zoltan G. Turi Tags: Societal Overview Source Type: research

HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement
The prevalence of atrial fibrillation (AF) is substantial and increasing. Stroke is common in AF and can have devastating consequences. Oral anticoagulants are effective in reducing stroke risk, but are underutilized.
Source: Heart Rhythm - May 13, 2015 Category: Cardiology Authors: David S. Frankel, Sarah E. Parker, Lynda E. Rosenfeld, Philip B. Gorelick Source Type: research

Pacing for treatment and prevention of atrial fibrillation: Is there an end to this story?Editorial Commentary
Pacemakers are frequently implanted in patients with atrial fibrillation (AF), which is the most common sustained cardiac arrhythmia with causal association with stroke, heart failure, cardiomyopathy, and all-cause mortality.1–5 In a general pacemaker population, AF can also develop frequently and progressively over time.6 Thus, as no surprise, the story of “pacing and AF” has been going around for a long time.1–7 The article by Padeletti et al8 in this issue of HeartRhythm perhaps adds a new twist.
Source: Heart Rhythm - May 5, 2015 Category: Cardiology Authors: Bharat K. Kantharia Tags: Editorial Commentary Source Type: research

Race and Gender Related Differences in Care for Patients Newly Diagnosed with Atrial Fibrillation
Atrial fibrillation (AF) is associated with increased risk of stroke and death. Uniform utilization of appropriate therapies for AF may help reduce those risks.
Source: Heart Rhythm - March 24, 2015 Category: Cardiology Authors: Prashant D. Bhave, Xin Lu, Saket Girotra, Hooman Kamel, Mary S. Vaughan Sarrazin Source Type: research

Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation
Atrial fibrillation (AF) is associated with an increased risk of stroke and death. Uniform utilization of appropriate therapies for AF may help reduce those risks.
Source: Heart Rhythm - March 24, 2015 Category: Cardiology Authors: Prashant D. Bhave, Xin Lu, Saket Girotra, Hooman Kamel, Mary S. Vaughan Sarrazin Source Type: research

Race- and gender-related differences in care for patients newly diagnosed with atrial fibrillation
Atrial fibrillation (AF) is associated with an increased risk of stroke and death. Uniform utilization of appropriate therapies for AF may help reduce those risks.
Source: Heart Rhythm - March 24, 2015 Category: Cardiology Authors: Prashant D. Bhave, Xin Lu, Saket Girotra, Hooman Kamel, Mary S. Vaughan Sarrazin Source Type: research

Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: a propensity matched study of 24,244 patients
Stroke is the major cause of morbidity and mortality related to atrial fibrillation (AF). Catheter ablation for AF is effective in reducing AF burden, but its impact on long-term stroke risk is unknown.
Source: Heart Rhythm - February 20, 2015 Category: Cardiology Authors: Peter A Noseworthy, Suraj Kapa, Abhishek J Deshmukh, Malini Madhavan, Holly Van Houten, Lindsey R Haas, Siva K Mulpuru, Christopher J McLeod, Samuel J Asirvatham, Paul A Friedman, Nilay D Shah, Douglas L Packer, D. Robert, Patricia E. Kern Source Type: research

Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients
Stroke is the major cause of morbidity and mortality related to atrial fibrillation (AF). Catheter ablation for AF is effective in reducing AF burden, but its impact on long-term stroke risk is unknown.
Source: Heart Rhythm - February 20, 2015 Category: Cardiology Authors: Peter A. Noseworthy, Suraj Kapa, Abhishek J. Deshmukh, Malini Madhavan, Holly Van Houten, Lindsey R. Haas, Siva K. Mulpuru, Christopher J. McLeod, Samuel J. Asirvatham, Paul A. Friedman, Nilay D. Shah, Douglas L. Packer Source Type: research

Glycated Hemoglobin and Risk of First Episode Stroke in Diabetic Patients with Atrial Fibrillation: A Cohort Study
Diabetes is associated with increased risk of stroke in patients with atrial fibrillation. Whether glycemic control, evaluated by glycated hemoglobin, affects the risk of stroke in diabetic patients with atrial fibrillation remains unknown.
Source: Heart Rhythm - January 19, 2015 Category: Cardiology Authors: W. Saliba, O. Barnett-Griness, M. Elias, G. Rennert Source Type: research

Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9–10, 2013
The Heart Rhythm Society convened a research symposium on December 9–10, 2013, in Washington, DC, that focused on the prevention of atrial fibrillation (AF) as well as AF-related stroke and morbidity. Attendees sought to summarize advances in understanding AF since a 2008 National Institutes of Health (NIH) conference on this topic1 and to identify continued knowledge gaps and current research priorities. The research symposium also sought to identify key deficiencies and opportunities in research infrastructure, operations, and methodologies.
Source: Heart Rhythm - November 17, 2014 Category: Cardiology Authors: David R. Van Wagoner, Jonathan P. Piccini, Christine M. Albert, Mark E. Anderson, Emelia J. Benjamin, Bianca Brundel, Robert M. Califf, Hugh Calkins, Peng-Sheng Chen, Nipavan Chiamvimonvat, Dawood Darbar, Lee Eckhardt, Patrick T. Ellinor, Derek V. Exner, Source Type: research

Cryptogenic stroke: Is silent atrial fibrillation the culprit?
Stroke without an identifiable cause is frightening to patients and their families and is frustrating for the caring physician. Approximately 30% of patients with cardiac implanted electronic devices have some evidence of atrial fibrillation (AF), and much of it is silent, asymptomatic, and previously unrecognized.
Source: Heart Rhythm - October 3, 2014 Category: Cardiology Authors: Taya V. Glotzer, Paul D. Ziegler Source Type: research